Related Experiment Video
Updated: Nov 29, 2025

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
Published on: February 26, 2013
Left atrial mechanics for secondary prevention from embolic stroke of undetermined source
Leyla Elif Sade1, Suzan Keskin1, Ufuk Can2
1Cardiology Department, University of Baskent, 54. sokak E blok No: 45 Bahcelievler, 06490 Ankara, Turkey.
Insights
Left atrial remodelling, measured by LA strain, can identify patients with embolic stroke of undetermined source (ESUS) even without detected atrial fibrillation. This echocardiographic assessment aids in secondary stroke prevention strategies.
Area of Science:
- Cardiology
- Neurology
- Medical Imaging
Background:
- Anticoagulation is crucial for stroke prevention in atrial fibrillation (AF) patients.
- Identifying AF in cryptogenic stroke (CS) patients is essential for appropriate treatment.
- Embolic stroke of undetermined source (ESUS) poses a diagnostic challenge without clear AF detection.
Purpose of the Study:
- To investigate the association between left atrial (LA) remodelling and ESUS.
- To determine if LA strain can predict AF in CS patients.
- To evaluate the utility of LA strain in identifying ESUS.
Main Methods:
- Prospective study of 186 patients with acute ischemic stroke and controls.
- Continuous ECG monitoring for paroxysmal AF detection, repeated after 12 months if initially undetected.
- Quantification of LA reservoir strain (LASr) and LA contraction strain (LASct) using speckle-tracking echocardiography.
Main Results:
- CS patients were divided into AF (n=39) and ESUS (n=58) groups.
- ESUS patients showed significantly worse LA strain metrics compared to other cause and control groups, despite no detected AF.
- LASr independently predicted CS and ESUS, outperforming traditional scores like CHA2DS2-VASc.
Conclusions:
- Echocardiographic assessment of LA remodelling, particularly LASr, is valuable for identifying ESUS.
- LA strain analysis offers potential for secondary prevention in ESUS patients.
- Quantifying LA remodelling can aid in risk stratification and treatment decisions for stroke patients.
Aims:
Anticoagulation is not justified unless atrial fibrillation (AF) is detected in cryptogenic stroke (CS) patients. We sought to explore whether left atrial (LA) remodelling is associated with embolic stroke of undetermined source (ESUS).
Methods And Results:
In this prospective study, we evaluated consecutively 186 patients in sinus rhythm who presented with an acute ischaemic stroke (embolic and non-embolic) and sex- and age-matched controls. We performed continuous electrocardiogram (ECG) monitoring to capture paroxysmal AF episodes as recommended by the guidelines. After 12 months of follow-up, continuous ECG monitoring was repeated in patients with undetected AF episodes. We quantified LA reservoir and contraction strain (LASr and LASct) by speckle-tracking, LA volumes by 3D echocardiography. Out of 186 patients, 149 were enrolled after comprehensive investigation for the source of ischaemic stroke and divided into other cause (OC) (n = 52) and CS (n = 97) groups. CS patients were also subdivided into AF (n = 39) and ESUS (n = 58) groups. Among CS patients, LA strain predicted AF independently from CHARGE-AF score and LA volume indices. ESUS group, despite no captured AF, had significantly worse LA metrics than OC and control groups. AF group had the worst LA metrics. Moreover, LASr predicted both CS (embolic stroke with and without AF) and ESUS (embolic stroke with no detected AF) independently from LAVImax and CHA2DS2-VASc score. LASr >26% yielded 86% sensitivity, 92% specificity, 92% positive, and 86% negative predictive values for the identification of ESUS (areas under curve: 0.915, P < 0.0001, 95% confidence interval: 0.86-0.97).
Conclusion:
Echocardiographic quantification of LA remodelling has great potential for secondary prevention from ESUS.
More Related Videos
Related Concept Videos
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Mitral Stenosis II: Clinical features and Diagnostic Tests
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Mitral Stenosis III: Medical Management

